← Back to Clinical Trials
Recruiting NCT07705061

NCT07705061 Hertel Exophthalmometry Values in Mexican Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07705061
Status Recruiting
Phase —
Sponsor Instituto de Oftalmología Fundación Conde de Valenciana
Condition Exophthalmometry
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2026-04-21
Primary Completion 2026-12-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Hertel Exophthalmometry

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2026-04-21 with a primary completion date of 2026-12-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Proptosis assessment using Hertel exophthalmometry is an essential part of the ophthalmic examination, but normal reference values vary among different populations. This observational study aims to establish normative Hertel exophthalmometry values in Mexican adults and to evaluate their association with demographic characteristics (such as age and sex) and systemic diseases. Healthy adult participants and adults with selected systemic conditions will undergo standardized Hertel exophthalmometry measurements. The findings are expected to provide population-specific reference values that may improve the clinical assessment of orbital diseases in the Mexican population.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years or older. * Mexican participants or individuals who self-identify as Mexican. * Ability to understand the study procedures and provide written informed consent. * Ability to undergo bilateral Hertel exophthalmometry. * Participants with or without previously diagnosed systemic diseases. Exclusion Criteria: * Active thyroid eye disease * History of orbital trauma or orbital fracture. * Previous orbital surgery, orbital decompression, or surgery that may alter globe position. * Presence or history of an orbital tumor, orbital inflammation, or orbital infection. * Craniofacial abnormalities or facial asymmetry that may interfere with Hertel exophthalmometry. * Ocular or eyelid conditions that prevent accurate positioning or measurement with the Hertel exophthalmometer. * Inability to cooperate with the examination or obtain a reliable exophthalmometry measurement.

Contact & Investigator

Central Contact

Roberto Ramirez Hernandez, MD, Ophthalmologist

✉ robert.rami.rr@gmail.com

📞 +525525137712

Frequently Asked Questions

Who can join the NCT07705061 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Exophthalmometry. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07705061 currently recruiting?

Yes, NCT07705061 is actively recruiting participants. Contact the research team at robert.rami.rr@gmail.com for enrollment information.

Where is the NCT07705061 trial being conducted?

This trial is being conducted at Mexico City, Mexico.

Who is sponsoring the NCT07705061 clinical trial?

NCT07705061 is sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology